Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
Technical Remarks When CGM is used in individuals with pre-existing diabetes, providers and patients should use fasting and postprandial glucose targets (whether measured by CGM or SMBG) as the basis for insulin adjustment and not a single glucose target of 63140 mg/dL When using CGM in conjunction with HCL, providers should be aware that not all HCL algorithms can meet these targets This recommendation applies to all types of pre-existing diabetes, including type 1 diabetes and type 2 diabetes There are limited data on the appropriate lower limit of the target for fasting or postprandial glucose in pregnancy
10.1186/s12951-025-03415-w 64 LuS
And no benefits were shown in the objective examination of patients movements, their own reports of symptom severity, or imaging findings
The analyte solutions were flowed over the immobilized protein surface for 80 seconds at a 25 L/min flow rate from low to high concentration and a 120-second dissociation time
